BioSpace News Archive

Policy

Update on independent review of Global Public Health Intelligence Network

In November 2020, the Minister of Health announced an independent panel would pursue the review of the Public Health Agency of Canada’s Global Public Health Intelligence Network.

March 20, 2021
·
1 min read
Drug Development

Strongbridge Biopharma plc Presents Detailed Results from Pivotal Phase 3 LOGICS Study of RECORLEV® (levoketoconazole) for the Treatment of Endogenous Cushing’s Syndrome at the 2021 Annual Meeting of the Endocrine Society (ENDO)

Strongbridge Recently Submitted a New Drug Application (NDA) for RECORLEV® (levoketoconazole) to the U.S. Food & Drug Administration

March 20, 2021
·
9 min read
Theratechnologies Announces New Data Demonstrating Tesamorelin’s Positive Effect on Immune Response Linked to Liver InflammationData presented at ENDO 2021

Theratechnologies Inc., a biopharmaceutical company focused on the development and commercialization of innovative therapies, is pleased to announce that new data, demonstrating the positive effect of tesamorelin on the circulation of immune activation markers associated with liver inflammation, was presented at The Endocrine Society’s annual meeting, ENDO 2021.

March 20, 2021
·
7 min read
Policy

Statement from the Chief Public Health Officer of Canada on March 20, 2021

The COVID-19 pandemic continues to create stress and anxiety for many Canadians, particularly those who do not have ready access to their regular support networks.

March 20, 2021
·
5 min read